Clinical (prescription) cannabis products were rescheduled in the united kingdom in 2018 — this permitted professional Medical professionals to prescribe cannabis-based mostly medicines in a restricted list of circumstances. Accessibility through the NHS continues to be tightly limited: cannabis-dependent merchandise tend to be only prescribed by